Articles tagged with "Safety"

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety

April 9, 2019 • By David Douglas

FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare

March 12, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Expands Safety Measures for Immediate Release Opioids

October 2, 2018 • By Michele B. Kaufman, PharmD, BCGP

EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray

August 8, 2018 • By Michele B. Kaufman, PharmD, BCGP

FDA Receives Reports of Loperamide Abuse

February 14, 2018 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Hip Fracture Rates After Bisphosphonate Drug Holidays, Plus More on Golimumab, Ustekinumab

December 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

Limbrel Linked to Possible Fatal Adverse Events

December 12, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Efficacy Studied Following Accelerated Drug Approvals; Plus Secukinumab Meets Benchmark for Psoriasis

November 9, 2017 • By Michele B. Kaufman, PharmD, BCGP

Rheumatology Drug Updates: Biosiomilar to Adalimumab Receives FDA Approval; plus Updates on Baricitinib, Tofacitinib, Bimekizumab

October 17, 2017 • By Mary Beth Nierengarten

Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?

October 17, 2017 • By Vanessa Caceres

1
2
3
…
13
Next Page »